Sat12162017

Last updateWed, 01 Oct 2014 1pm

Apixaban reduces the risk of stroke by more than half compared with aspirin - Reuters (article link)

- Connolly said apixaban reduced the rate of strokes by 52% compared with aspirin in the patients studied.
- The annual rate of strokes in patients on apixaban was 1.5% compared to 3.3% for those taking aspirin.

The annual rate of major bleeding was not significantly different between patients on apixaban and aspirin, at 1.4% and 1.2% respectively, and there was also no significant difference in clinically relevant non-major bleeds.

Drug cuts stroke risk by half vs aspirin: study
http://www.reuters.com/article/idUSTRE67U3J320100831

(Reuters) - An experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.